Romidepsin
- Product NDC
- 70710-2183
- Requested package NDC
- 70710-2183-3
- 11-digit product format
- 707102183
- Labeler code
- 70710
- Product ID
- 70710-2183_d4d16f51-b1f4-4705-8355-f5d89dc05581
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Romidepsin
- Dosage form
- KIT
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Application
- ANDA220783
- Marketing category
- ANDA
- Marketing start
- 2026-11-01
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220783-001 | ROMIDEPSIN | ROMIDEPSIN | 10MG/VIAL | POWDER / INTRAVENOUS | AP | 2026-10-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A220783-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A220783-001 | ROMIDEPSIN | 10MG/VIAL | POWDER / INTRAVENOUS | AP | 2026-10-19 | d4dbc9d85df4… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A220783-001 | AP | 1 | d4dbc9d85df4… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Romidepsin
- Listing expiration
- 2027-12-31
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 877513 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7e306d8e-0e00-4f1c-b179-2027d44092ce | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Romidepsin | ROMIDEPSIN | Zydus Pharmaceuticals USA Inc. | 7e306d8e-0e00-4f1c-b179-2027d44092ce | 2026-11-05 | Warnings, Adverse reactions | 220783 ANDA220783 70710-2183-3 70710-2183 70710218303 |
| Romidepsin | ROMIDEPSIN | Zydus Lifesciences Limited | 7994d49f-3e1b-4f37-a06f-f31e9ed1a3fa | 2026-10-30 | 220783 ANDA220783 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 70710-2183-3 | 70710218303 | 1 KIT in 1 CARTON (70710-2183-3) * 2 mL in 1 VIAL, GLASS (70710-2181-1) * 2.2 mL in 1 VIAL, GLASS (70710-2182-1) | 1 kit | 2026-11-01 | Yes | No | Current |